FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/16/2026
Back to search
Official data from USPTO
PALDOMSA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
07/16/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
02/20/2025
Registration date
12/09/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/09/2025
Last transaction
07/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
IE
Examiner
O'BRIEN, JENNIFER LYNN
Law office
N30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
G. U. (pessoa física)
Representatives
Cynthia Smuzynska Gilead Sciences, Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/26/2026
FIMP
FINAL DISPOSITION PROCESSED
06/25/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/09/2026
CHPN
POST PUBLICATION AMENDMENT – NOT ENTERED
01/22/2026
APET
ASSIGNED TO PETITION STAFF
01/22/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/09/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
11/13/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/21/2025
PUBO
PUBLISHED FOR OPPOSITION
10/21/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/15/2025
RFNT
REFUSAL PROCESSED BY IB
09/27/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/24/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/22/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/22/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/22/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/09/2025
RFRR
REFUSAL PROCESSED BY MPU
09/09/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/01/2025
CNRT
NON-FINAL ACTION WRITTEN
07/31/2025
DOCK
ASSIGNED TO EXAMINER
07/25/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/25/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/25/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/24/2025
Continuous trademark protection
Get notified about every new filing that threatens PALDOMSA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.